Sight Sciences (SGHT) Cash from Investing Activities (2020 - 2026)
Sight Sciences' quarterly Cash from Investing Activities came in at -$60000.0 in Q1 2026, down 138.46% quarter-over-quarter from $156000.0 in Q4 2025.
Sight Sciences has reported Cash from Investing Activities for 7 years, with the latest figure at -$60000.0 in Q1 2026.
- For the quarter ending Q1 2026, Cash from Investing Activities changed N/A year-over-year to -$60000.0; the trailing twelve-month figure through Mar 2026 stood at -$284000.0 (down 5.97% YoY), and the FY2025 full-year result was -$224000.0, up 41.82% from the prior year.
- Cash from Investing Activities for Q1 2026 stood at -$60000.0, down from $156000.0 in the prior quarter.
- The five-year high for Cash from Investing Activities was $156000.0 in Q4 2025, with the low at -$342000.0 in Q2 2022.
- Average Cash from Investing Activities over 5 years is -$151875.0, with a median of -$133000.0 recorded in 2022.
- Peak annual rise in Cash from Investing Activities reached 213.87% in 2025, while the deepest fall reached 233.33% in 2025.
- Tracing SGHT's Cash from Investing Activities over 5 years: stood at -$129000.0 in 2022, then slumped by 104.65% to -$264000.0 in 2023, then jumped by 48.11% to -$137000.0 in 2024, then soared by 213.87% to $156000.0 in 2025, then sank by 138.46% to -$60000.0 in 2026.
- The last three Cash from Investing Activities figures came in at -$60000.0 (Q1 2026), $156000.0 (Q4 2025), and -$170000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -20.32 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -185.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -816.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -591.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -92.80 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -475.32 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | -298.50 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -2.50 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | -217.20 Mn |
| 10 | Sight Sciences | 247.60 Mn | 162.64 Mn | 16.98 Mn | -60,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -60,000.00 |
| Mar 31, 2026 | -60,000.00 |
| Dec 31, 2025 | 156,000.00 |
| Dec 31, 2025 | 156,000.00 |
| Sep 30, 2025 | -170,000.00 |
| Sep 30, 2025 | -170,000.00 |
| Jun 30, 2025 | -210,000.00 |
| Jun 30, 2025 | -210,000.00 |
| Dec 31, 2024 | -137,000.00 |
| Dec 31, 2024 | -137,000.00 |
| Sep 30, 2024 | -51,000.00 |
| Sep 30, 2024 | -51,000.00 |
| Jun 30, 2024 | -80,000.00 |
| Jun 30, 2024 | -80,000.00 |
| Mar 31, 2024 | -117,000.00 |
| Mar 31, 2024 | -117,000.00 |
| Dec 31, 2023 | -264,000.00 |
| Dec 31, 2023 | -264,000.00 |
| Sep 30, 2023 | -304,000.00 |
| Sep 30, 2023 | -304,000.00 |
| Jun 30, 2023 | -97,000.00 |
| Jun 30, 2023 | -97,000.00 |
| Mar 31, 2023 | -126,000.00 |
| Mar 31, 2023 | -126,000.00 |
| Dec 31, 2022 | -129,000.00 |
| Dec 31, 2022 | -129,000.00 |
| Sep 30, 2022 | -272,000.00 |
| Sep 30, 2022 | -272,000.00 |
| Jun 30, 2022 | -342,000.00 |
| Jun 30, 2022 | -342,000.00 |
| Mar 31, 2022 | -227,000.00 |
| Mar 31, 2022 | -227,000.00 |
| Dec 31, 2021 | -157,000.00 |
| Dec 31, 2021 | -157,000.00 |
| Sep 30, 2021 | -287,000.00 |
| Sep 30, 2021 | -287,000.00 |
| Jun 30, 2021 | -265,000.00 |
| Jun 30, 2021 | -265,000.00 |
| Mar 31, 2021 | -104,000.00 |
| Mar 31, 2021 | -104,000.00 |
| Dec 31, 2020 | -302,000.00 |
| Dec 31, 2020 | -302,000.00 |
| Sep 30, 2020 | -119,000.00 |
| Sep 30, 2020 | -119,000.00 |